Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III randomized double-blind trial of RJ-0265 (ciclopirox nail lacquer) vs placebo in toenail onychomycosis
2016-003784-19Phase 3Completed
- Sponsor
- Laboratorio Reig Jofre, S.A.
- Start
- Apr 2017
- Modality
- Small Molecules, Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in onychomycosis comparing RJ-0265 (Ony-Tec, ciclopirox) with Placebo (2 arms). Primary endpoint: Complete cure rate at week 52. Started Apr 2017; status: completed.
02
Drugs
Ciclopoli
03
Conditions
onychomycosis
Beyond the preview
Go deeper on 2016-003784-19.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2016-003784-19.